Long-term Treatment with Suberythropoietic Epo is Vaso- and Neuroprotective in Experimental Diabetic Retinopathy-Reference-Cited by-同舟云学术

Long-term Treatment with Suberythropoietic Epo is Vaso- and Neuroprotective in Experimental Diabetic Retinopathy

Published:2011 Issue:6 Volume:27 Page:769-782
ISSN:1421-9778
Container-title:Cellular Physiology and Biochemistry
language:en
Short-container-title:Cell Physiol Biochem

Author:

Wang Qian,Gorbey Stefan,Pfister Frederick,Höger Simone,Dorn-Beineke Andrea,Krügel Katja,Berrone Elena,Wu Liang,Korff Thomas,Lin Jihong,Busch Stefanie,Reichenbach Andreas,Feng Yuxi,Hammes Hans-Peter

Publisher

S. Karger AG

Subject

Physiology

Reference69 articles.

1. Diabetic Retinopathy

2. Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice

3. Pericytes and the Pathogenesis of Diabetic Retinopathy

4. Pericytes and the Pathogenesis of Diabetic Retinopathy

5. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD8+T Cell-Related Gene Biomarkers in Macular Edema of Diabetic Retinopathy;Frontiers in Endocrinology;2022-07-22

2. The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers;International Journal of Molecular Sciences;2022-07-08

3. Recent Advancements in the Medical Treatment of Diabetic Retinal Disease;International Journal of Molecular Sciences;2021-08-31

4. Use of erythropoietin in ophthalmology: a review;Survey of Ophthalmology;2021-06

5. Protective effect of Soluble Epoxide Hydrolase Inhibition in Retinal Vasculopathy associated with Polycystic Kidney Disease;Theranostics;2020